Literature DB >> 913972

Duodenal ulcerogens, cysteamine and propionitrile, stimulate serum gastrin levels in the rat.

L M Lichtenberger, S Szabo, J S Trier.   

Abstract

Cysteamine and propionitrile are members of a family of compounds which induce the formation of acute duodenal ulcers in fasted and fed rats. Gastric acid secretion is increased by both agents, and acid hypersecretion appears to be required for ulcer formation. To determine the role of gastrin in the ulcerogenic mechanism, cysteamine and propionitrile were administered to fasted rats and their effect on fasting and food-stimulated serum gastrin levels was studied. Intragastric administration of cysteamine caused a 3- to 4-fold increase in fasting serum gastrin levels over the values of controls. Propionitrile was a less effective stimulant of gastrin release, causing a 1.5- to 2-fold increase in gastrin levels over matched control rats. The food-stimulated rise in serum gastrin levels after either a chow meal or intragastric instillation of a peptone solution was markedly enhanced by cysteamine pretreatment. Three hours after feeding the serum gastrin levels of cysteamine pretreated rats were 6 times higher than those of fed controls. The high serum gastrin levels of cysteamine-pretreated fed rats could not be explained solely by the additive effects of cysteamine and food, indicating that a potentiating interaction may exist between the two stimulants of gastrin release. The importance of this drug-induced stimulation of gastrin release, under both fasted and fed conditions, in the ulcerogenic process has yet to be ascertained.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 913972

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  17 in total

1.  Esomeprazole therapy for gastric acid hypersecretion in children with cystinosis.

Authors:  Ranjan Dohil; Meredith Fidler; Bruce Barshop; Robert Newbury; Zachary Sellers; Reena Deutsch; Jerry Schneider
Journal:  Pediatr Nephrol       Date:  2005-08-24       Impact factor: 3.714

2.  Duodenal ulcerogens cysteamine and propionitrile decrease duodenal neutralization of acid in the rat.

Authors:  R S Adler; G T Gallagher; S Szabo
Journal:  Dig Dis Sci       Date:  1983-08       Impact factor: 3.199

3.  Pathogenesis of duodenal ulceration produced by cysteamine or propionitrile: influence of vagotomy, sympathectomy, histamine depletion, H-2 receptor antagonists and hormones.

Authors:  S Szabo; L R Haith; E S Reynolds
Journal:  Dig Dis Sci       Date:  1979-06       Impact factor: 3.199

4.  Gastric and duodenal anti-ulcer activity of sulpiride, a dopamine D2 receptor antagonist, in rats.

Authors:  J K Desai; N S Parmar
Journal:  Agents Actions       Date:  1994-10

5.  Effect of cimetidine and carbenoxolone on cysteamine-induced ulcers: a study of gastric mucosal histamine and histamine formation capacity in rat.

Authors:  W K Man; S Boesby; R Mendez-Diaz; J Spencer
Journal:  Agents Actions       Date:  1984-12

6.  Effect of cysteamine on gastroduodenal mucosal histamine in rat.

Authors:  S Boesby; W K Man; R Mendez-Diaz; J Spencer
Journal:  Gut       Date:  1983-10       Impact factor: 23.059

7.  Duodenal ulcer disease. Animal model: cysteamine-induced acute and chronic duodenal ulcer in the rat.

Authors:  S Szabo
Journal:  Am J Pathol       Date:  1978-10       Impact factor: 4.307

8.  The effect cystamine on gastric secretion in the rat.

Authors:  M E Parsons; K T Bunce; A Currington; F Matheson; G Pipkin
Journal:  Agents Actions       Date:  1979-08

9.  Role of iron in the pathogenesis of cysteamine-induced duodenal ulceration in rats.

Authors:  Tetyana Khomenko; Sandor Szabo; Xiaoming Deng; Hideki Ishikawa; Gregory J Anderson; Gordon D McLaren
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-04-02       Impact factor: 4.052

10.  Effects of epidermal growth factor on alkaline secretion and mucus formation in rat duodenum exposed to luminal acid.

Authors:  I Yoshikawa
Journal:  Gastroenterol Jpn       Date:  1993-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.